Table 3 Levels of glucose, insulin and insulin related proteins in breast cancer survivors over time (n = 10 per group)
| Â | Week 0 | Week 6 | Week 12 | Week 18 |
|---|---|---|---|---|
Glucose (mg/dL) | ||||
 CR | 80.7 (72.1, 89.3) | 79.8 (71.2, 88.4) | 75.5 (66.9, 84.1) | 78.7 (70.1, 87.3) |
 WM | 96.5 (87.9, 105.1) | 91.7 (93.1, 100.3) | 92.4 (83.8, 101) | 94.5 (85.9, 103.1) |
Insulin (mU/L) | ||||
 CR | 9 (2.7, 15.3) | 7.2 (0.8, 13.5) | 6 (0, 12.3) | 6.9 (0.6, 13.2) |
 WM | 19.4 (13.1, 25.7) | 14.7 (8.4, 21) | 13.6 (7.3, 19.9) | 13.5 (7.2, 19.8) |
HOMA index | ||||
 CR | 1.8 (-0.3, 3.9) | 1.4 (0, 3.5) | 1.1 (0, 3.3) | 1.4 (0, 3.5) |
 WM | 5.4 (3.3, 7.6) | 3.6 (1.5, 5.7) | 3.2 (1.1, 5.4) | 3.3 (1.2, 5.4) |
QUICKI | ||||
 CR | 0.6 (0.6, 0.7) | 0.7 (0.6, 0.8) | 0.8 (0.7, 0.9) | 0.8 (0.7, 0.9) |
 WM | 0.5 (0.4, 0.6) | 0.6 (0.5, 0.7) | 0.6 (0.5, 0.7) | 0.6 (0.5, 0.7) |
IGF-1 (ng/mL) | ||||
 CR | 103.8 (80, 127.6) | 106.8 (83, 130.6) | 108 (84.3, 131.8) | 117.4 (93.7, 141.2) |
 WM | 99.3 (75.5, 123.1) | 85 (61.3, 108.8) | 98 (74.3, 121.8) | 105.1 (81.4, 128.9) |
IGFBP-3 (ng/mL) | ||||
 CR | 1855 (1476, 2234) | 1833 (1455, 2212) | 1792 (1413, 2171) | 1740 (1362, 2119) |
 WM | 1900 (1521, 2279) | 1578 (1199, 1957) | 1812 (1434, 2191) | 1827 (1448, 2205) |